Navigation Links
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

NEW YORK, March 19 /PRNewswire/ -- QED International Associates Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced the quarterly rebalancing of the Indexes.

The following securities will be added and deleted in the Indexes effective before the opening of trading on NYSE Arca March 24, 2008.

Autoimmune-Inflammation Index (HHA)


GW Pharmaceuticals, Inc (LSE: GWP.L)

Human Genome Sciences (Nasdaq: HGSI)

Ligand Pharmaceuticals, Inc. (Nasdaq: LGND)


Fornix Biosciences N.V. (Amsterdam: FORBI.AS)


Mitsubishi Tanabe Pharma Corporation (TSE: 4508)

Cancer Index (HHK)


Shire PLC (Nasdaq: SHPGY)


Ark Therapeutics Group Plc (LSE: AKT.L)

Cardio Devices Index (HHE)


Biosphere Medical, Inc. (Nasdaq: BSMD)


Zoll Medical Corp. (Nasdaq: KERX)


Dyanvax Technologies (Nasdaq: DVAX)

Synta Pharmaceuticals Corp. (Nasdaq: SNTA)

Enabling Technologies Index (HHV)


Hillenbrand Industries (NYSE: HB)


Eurand N.V. (Nasdaq: EURX)

GI/Gender Index (HHU)


AEterna Zentaris (Nasdaq: AEZS)

King Pharmaceuticals (NYSE: KG)

Nastech Pharmaceutical (Nasdaq: NSTK)


Columbia Laboratories Inc. (Nasdaq: CBRX)

Eisai Co. Ltd. (Tokyo Stock Exchange: 4523)

Mylan, Inc. (NYSE: MYL)

Metabolic-Endocrine Disorders Index (HHM)


Depomed Inc. (Nasdaq: DEPO)

Emisphere Technologies Inc. (Nasdaq: EMIS)

Flamel Technologies SA ADS (Nasdaq: FLML)

Hospira Inc. (NYSE: HSP)

Human Genome Sciences, Inc. (Nasdaq: HGSI)

Indevus Pharmaceuticals Inc. (Nasdaq: IDEV)

Ipsen Ltd. (Paris: IPN.PR)

Nastech Pharmaceutical Co. (Nasdaq: NSTK)

Nektar Therapeutics (Nasdaq: NKTR)

NicOx S.A. (Paris: NCOX)

OSI Pharmaceuticals Inc. (Nasdaq: OSIP)

ProStrakan Group Plc (LSE: PSK.L)

Solvay S.A. (Brussels: SVYSY)


Altus Pharmaceuticals Inc. (Nasdaq: ALTU)

Amicus Therapeutics, Inc. (Nasdaq: FOLD)

Biodel Inc. (Nasdaq: BIOD)

CombinatoRx Inc. (Nasdaq: CRXX)

GW Pharmaceuticals Plc (LSE: GWP.L)

Incyte Corp. (Nasdaq: INCY)

Orexigen Therapeutics, Inc. (Nasdaq: OREX)

Repros Therapeutics Inc. (Nasdaq: RPRX)

Sangamo BioSciences Inc. (Nasdaq: SGMO)

Sirtris Pharmaceuticals, Inc. (Nasdaq: SIRT)

SuperGen Inc. (Nasdaq: SUPG)

Transition Therapeutics Inc. (Nasdaq: TTHI)

XOMA Ltd. (Nasdaq: XOMA)

Neuroscience Index (HHN)


Neurochem Inc. (Nasdaq: NRMX)


Caraco Pharmaceutical Laboratories Ltd. (Amex: CPD)

Ophthalmology Index (HHZ)


Insite Vision Inc. (Amex: ISV)


King Pharmaceuticals (NYSE: KG)

Patient Care Services Index (HHB)


Fresenius Medical Care (XETRA: FME.DE)


Coventry Health Care Inc. (NYSE: CVH)

The rebalanced Indexes, including the rebalanced Index Shares, are based on the closing prices as of March 14, 2008.

In accordance with the Exemptive Order, a complete list of the constituents reflecting the rebalancing will be posted at

About QED International Associates

QED International, based in New York, is a leading financial industry consulting firm specializing in quantitative modeling and the design, development and maintenance of indexes and Exchange Traded Funds. For more information, visit the company's website at

Ticker=ZOLL" onClick="var s=s_gi(s_account); var hd1 = document.getElementById('headline');,'o',getLinkName('Company Sanpshot'));" >ZOLL)

Cardiology Index (HRD)


Encysive Pharmaceuticals, Inc. (Nasdaq: ENCY)

Human Genome Sciences, Inc (Nasdaq: HGSI)

Vical, Inc (Nasdaq: VICL)


Mitsubishi Tanabe Pharma Corporation (TSE: 4508)

Sangamo BioSciences Inc (Nasdaq: SGMO)

Sciele Pharma, Inc. (Nasdaq: SCRX)

Composite Index (HHQ)


Advanced Medical Optics, Inc. (NYSE: EYE)

Align Technology Inc. (Nasdaq: ALGN)

Array Biopharma Inc. (Nasdaq: ARRY)

ArthroCare Corp. (Nasdaq: ARTC)

Endo Pharmaceuticals Hldgs. (Nasdaq: ENDP)

Fresenius Medical Care AG (XETRA: FME.DE)


GENMAB A/S (Copenhagen: GEN.CO)

H. LUNDBECK A/S (Copenhagen: LUN.CO)

Human Genome Sciences (Nasdaq: HGSI)

Imclone Systems (Nasdaq: IMCL)

Inverness Medical Innovations (Amex: IMA)

Invitrogen Corp. (Nasdaq: IVGN)

Medarex Inc. (Nasdaq: MEDX)

Medicis Pharmaceutical (NYSE: MRX)

Mentor Corp. (NYSE: MNT)

ONYX Pharmaceuticals Inc. (Nasdaq: ONXX)

PDL BioPharma, Inc. (Nasdaq: PDLI)

Pharmion Corp. (Nasdaq: PHRM)

Progenics Pharmaceuticals Inc. (Nasdaq: PGNX)

Regeneron Pharmaceuticals (Nasdaq: REGN)

Respironics Inc. (Nasdaq: RESP)

Sepracor Inc. (Nasdaq: SEPR)

Theravance Inc. (Nasdaq: THRX)

United Therapeutics Corp. (Nasdaq: UTHR)

Valeant Pharmaceuticals Int'l (NYSE: VRX)

Vertex Pharmaceuticals (Nasdaq: VRTX)


Adolor Corp. (Nasdaq: ADLR)


Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY)

Alpharma Inc. (NYSE: ALO)

Altus Pharmaceuticals Inc. (Nasdaq: ALTU)

AMAG Pharmaceuticals Inc. (Nasdaq: AMAG)


Ark Therapeutics (LSE: AKT.L)

Bavarian Nordic A/S (Copenhagen: BAVA.CO)

Caraco Pharmaceutical Laboratories Ltd. (Amex: CPD)

Cardiome Pharma Corp. (Nasdaq: CRME)

Coventry Health Care Inc. (NYSE: CVH)



Discovery Laboratories Inc. (Nasdaq: DSCO)

Eisai Co. Ltd. (TSE: 4523.T)

Encysive Pharmaceuticals Inc. (Nasdaq: ENCY)

Enzo Biochem Inc. (NYSE: ENZ)


Exelixis Inc. (Nasdaq: EXEL)

Flamel Technologies (Nasdaq: FLML)

Illumina Inc. (Nasdaq: ILMN)

Incyte Corporation (Nasdaq: INCY)

Integra LifeSciences Holdings (Nasdaq: IART)

Meda AB (Stockholm: MEDAA.ST)

Mitsubishi Tanabe Pharma (TSE: 4508.T)

Taisho Pharmaceutical Co., Ltd. (TSE: 4535.T)

Dermatology and Wound Index (HRW)


Shire PLC (ADR) (Nasdaq: SHPGY)

SkyePharma Plc (LSE: SKP.LN)


Standard Chemical & Pharm. Co., Ltd. (TSE: 1720)

Taisho Pharmaceutical Co., Ltd. (TSE: 4535)

Diagnostics Index (HHD)


CR Bard, Inc. (NYSE: BCR)

IDEXX Laboratories (Nasdaq: IDXX)


Bruker Corporation (Nasdaq: BRKR)

Halozyme Therapeutic (Nasdaq: HALO)

Emerging Cancer Index (HHJ)


Adventrx Pharmaceuticals, Inc. (Amex: ANX)

Keryx Biopharmaceuticals, Inc. (Nasdaq:

SOURCE QED International Associates Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PRA International Announces New Office Opening in Mumbai
2. Solcara Helps AstraZeneca Set International Benchmark for Global Media Relations
3. Mirion Technologies to Showcase New Product Offerings for the Nuclear Industry During 10th Annual China International Nuclear Industry Exhibition
4. International Diabetes Federation gives grant to UMDNJ-University Hospital in Newark
5. Chindex International, Inc. Announces Three-For-Two Stock Split
6. Resources Top 400,000 in Hopkins International Information Service
7. Egyptian foot care center recieves International Diabetes Federation grant
8. Project Concern International Receives a US$1 Million Grant From the Starbucks Foundations Ethos Water Fund to Provide Safe Water and Sanitation Services in Tanzania
9. Position Statement Regarding Lt. Gov. Paterson from Tara A. Cortes, Ph.D, RN President and CEO of Lighthouse International
10. Mettler-Toledo International Inc. Announces Webcast of Presentation at Lehman Brothers Global Healthcare Conference
11. Autism Speaks to Celebrate World Autism Awareness Day with Day-Long Series of International Events on April 2
Post Your Comments:
(Date:12/1/2015)... PITTSBURGH, PA (PRWEB) , ... December 01, 2015 ... ... or imaging facilities, radiographic technicians must mark the film for accurate interpretation by ... keep track of. Fortunately, an inventor from Sacramento, Calif., has found a way ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... it has been selected as a finalist in this year’s Fierce Innovation Awards: ... Next IT Healthcare was recognized as a finalist in the category of Digital ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s latest white paper, ... addresses a main “pain point” for merging or aligning healthcare provider organizations—when mergers ... is signed. This quick-read guidance suggests that failing to recognize the power ...
(Date:12/1/2015)... ... 01, 2015 , ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, ... , The order will be from the China Disabled Persons’ Federation, a central government ... effective solution for children and adults suffering from severe and profound hearing loss ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... companies, announced today that it has officially launched a sleek, mobile-ready and user-centric ... that his company’s new website clearly outlines the benefits that its SEO services ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015  Lexicon ... today that top-line data from its TELECAST ... etiprate in treating carcinoid syndrome in cancer ... the clinical benefit observed in its pivotal ... as a companion to TELESTAR primarily to ...
(Date:12/1/2015)... 2015 North America ... with analysis and forecast of revenue. --> ... segments the concerned market with analysis and forecast of ... Report "North American Orthobiologics Market by Type (Bone Allograft, ... Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Point-of-Care Testing) ...
(Date:12/1/2015)... , December 1, 2015 ... the addition of the  "2016 Shigella ... Innovative Technologies, Competitive Strategies, Emerging Opportunities--US, ... Japan"  report to their offering. ... the addition of the  "2016 Shigella ...
Breaking Medicine Technology: